Synthesis and Medicinal Importance of Dibenzazepine Derived Compounds: A Review

Neha Garg; Priyanka Jain; Sudesh Neyol; Adarsh Sahu; Dharmendra Jain

doi:10.5281/

Authors

Neha Garg Department of Chemistry, Banasthali University, Banasthali (Rajasthan), INDIA Author
Priyanka Jain Department of Chemistry, Banasthali University, Banasthali (Rajasthan), INDIA Author
Sudesh Neyol Department of Chemistry, Banasthali University, Banasthali (Rajasthan), INDIA Author
Adarsh Sahu Dept. of Pharmaceutical Sciences, Dr. H. S. Gour Central University, Sagar (MP), India Author
Dharmendra Jain Dept. of Pharmaceutical Sciences, Dr. H. S. Gour Central University, Sagar (MP), India Author

DOI:

https://doi.org/10.5281/

Keywords:

dibenzazepine, 1.4, benzodiazepine, benzazepines, AZEPINE, anxiolytic

Abstract

Heterocycles incorporating seven-membered rings in their molecules have found wide applications in medicinal chemistry due to their remarkable pharmaceutical effects. Among the seven-membered rings, the dibenzazepine rings have been found to be associated with diverse pharmacological activities such as antiviral, anticancer, anticonvulsant, antidepressant, anti-insecticidal, vasopressin (AVP) antagonist activities. Among azepine derivatives, benzene-fused azepines have been widely studied due to their various applications. In this review, we have discussed the medicinal importance of derivatives of seven-membered rings containing nitrogen heterocyclic compounds.

References

[1] Albright, J. D.; Santos, E. G. D.; Dusza, J. P.; Chan, P. S.; Coupet, J.; Ru, X.; Mazandarani, H. The synthesis and vasopressin (AVP) antagonist activity of a novel series of N-aroyl-2, 4, 5, 6-tetrahydropyrazolo [3, 4-d] thieno [3, 2-b] azepines Bioorg. Med. Chem. Lett. 2000, 10, 695-698.

[2] Szantay, C.; Bolcskei, H.; Gacs-Baitz, E. Synthesis of vinca alkaloids and related compounds XLVIII synthesis of (+)-catharanthine and (±)-allocatharanthine. Tetrahedron 1990, 46, 1711-1732.

[3] Kometani, T.; Shiotani, S. Synthesis and analgetic activity of some benzomorphan analogs. J. Med. Chem. 1978, 21, 1105-1110.

[4] Acquas, E.; Di Chiara, G. Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum. Eur. J. Pharmacol. 1999, 383, 275-279.

[5] Rosowsky, A.; Cody, V.; Galitsky, N.; Fu, H.; Papoulis, A. T.; Quenner, S. F. Structure-based design of selective inhibitors of dihydrofolate reductase: synthesis and antiparasitic activity of 2, 4-diaminopteridine analogues with a bridged diarylamine side chain. J. Med. Chem. 1999, 42, 4853-4860.

[6] Kemp, D. S.; Carter, J. S. Amino acid derivatives that stabilize secondary structures of polypeptides. 4. Practical synthesis of 4-(alkylamino)-3-cyano-6-azabicyclo [3.2. 1] oct-3-enes (ben derivatives) as. gamma.-turn templates. J. Org. Chem. 1989, 54, 109-115.

[7] Kollur, S.P., Castro, J.O., Frau, J. and Glossman-Mitnik, D., 2019. Chemical synthesis, spectroscopic studies, chemical reactivity properties and bioactivity scores of an azepin-based molecule. Journal of Molecular Structure, 1180, pp.300-306.

[8] Kaur, N. Expedient protocol for the installation of thiadiazole on 2-position of 1, 4-benzodiazepin-5-carboxamide through a phenoxyl spacer. Int. J. Pharm. Bio. Sci. 2013, 4, 366-373.

[9] Storer, R. I.; Brennan, P. E.; Brown, A. D.; Bungay, P. J. Multiparameter optimization in CNS drug discovery: design of pyrimido [4, 5-d] azepines as potent 5-hydroxytryptamine 2C (5-HT2C) receptor agonists with exquisite functional selectivity over 5-HT2A and 5-HT2B receptors. J. Med. Chem. 2014, 57, 5258-5269.

[10] Guzikowski, A. P.; Cai, S. X.; Espitia, S. A. Analogs of 3-Hydroxy-1 H-1-benzazepine-2, 5-dione: Structure− Activity Relationship at N-Methyl-d-aspartate Receptor Glycine Sites. J. Med. Chem. 1996, 39, 4643-4653.

[11] Cho, H.; Murakami, K.; Nakanishi, H. Synthesis and Structure− Activity Relationships of 5, 6, 7, 8-Tetrahydro-4 H-thieno [3, 2-b] azepine Derivatives: Novel Arginine Vasopressin Antagonists. J. Med. Chem. 2004, 47, 101-109.

[12] Smith, B. M.; Smith, J. M.; Tsai, J. H. Discovery and structure− activity relationship of (1 R)-8-chloro-2, 3, 4, 5-tetrahydro-1-methyl-1 H-3-benzazepine (Lorcaserin), a selective serotonin 5-HT2C receptor agonist for the treatment of obesity. J. Med. Chem. 2008, 51, 305-313.

[13] Scartoni, V.; Fiaschi, R.; Catalano, S.; Morelli, I.; Marsili, A. The aporhoeadane alkaloids. J. Chem. Soc. 1979, 1, 1547.

[14] Song, C.; Walker, D. B.; Swager, T. M. Conducting Thiophene-Annulated Azepine Polymers. Macromolecules. 2010, 43, 5233-5237.

[15] Waly, M. A. Carbonyl-Enamine a New Mode for Azepine Ring Closure: Synthesis and Characterization of Pyrazino [2, 3-c] azepine, as a New Ring System. Acta Chim. Slov. 2008, 55, 343-349.

[16] Camara, C. A.; Pinto, A. C.; Vargas, M. D.; Schpector, J. Z. Azepines from the intramolecular Prins cyclization of an aminoderivative of lapachol. Tetrahedron, 2002, 58, 6135-6140.

[17] Erian, A.W., Sherif, S.M. and Gaber, H.M., 2003. The chemistry of α-haloketones and their utility in heterocyclic synthesis. Molecules, 8(11), pp.793-865.

[18] Sahu, A., Kumar, D. and Agrawal, R.K., 2017. Antileishmanial drug discovery: synthetic methods, chemical characteristics, and biological potential of quinazolines and its derivatives. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents), 16(1), pp.3-32.

[19] Sahu, A., Sahu, P. and Agrawal, R., 2020. A Recent Review on Drug Modification Using 1, 2, 3-triazole. Current Chemical Biology, 14(2), pp.71-87.

[20] Sahu, A., Sahu, P. and Agrawal, R., 2019. Synthesis, Pharmacological and Toxicological Screening of Penicillin–Triazole Conjugates (PNTCs). ACS omega, 4(17), pp.17230-17235.

[21] Sahu, A., 2021. Advance Synthetic Approaches to 1, 2, 3-triazole Derived Compounds: State of the Art 2004-2020. Current Organocatalysis, 8(3), pp.271-288.

[22] Matsuhisa, A.; Kikuchi, K.; Sakamoto, K.; Yatsu T.; Tanaka, A. Nonpeptide Arginine Vasopressin Antagonists for Both V1A and V2 Receptors: Synthesis and Pharmacological Properties of 4'-[5-(Substituted Methylidene)-2, 3, 4, 5-tetrahydro-1H-1-benzoazepine-1-carbonyl] benzanilide and 4'-[5-(Substituted Methyl)-2, 3-dihydro-1H-1-benzoazepine-1-carbonyl] benzanilide Derivatives. Chem. Pharm. Bull. 1999, 47 (3), 329-339.

[23] Sadashiva, M. P.; Doreswamy, B. H.; Basappa Rangappa, K. S.; Sridhar, M. A.; Shashidhara Prasad, J. Synthesis and crystal structure of 5-allyl-5 H dibenzo [b, f] azepine. J. Chem. Cryst. 2005, 35, 171-175.

[24] Sadashiva, M. P.; Basappa, NanjundaSwamy, S.; Li, F.; Manu, K. A.; Sengottuvelan, M.; Prasanna, D. S.; Anilkumar, N. C.; Sethi, G.; Sugahara, K.; Rangappa, K. S. Anti-cancer activity of novel dibenzo [b, f] azepine tethered isoxazoline derivatives. BMC Chem Biol. 2012, 12, 5. doi:10.1186/1472-6769-12-5

[25] Dulsat, C.; Mealy, N.; Castaner, R.; Bolos, J. Eslicarbazepine acetate. Drugs Fut. 2009, 34 (3), 189. doi: 10.1358/dof.2009.034.03.1352675

[26] Brayfield, A. The Complete Drug Reference (The Royal Pharmaceutical Society of Great Britain) 2013.

[27] Mazza, M.; Della Marca, G.; Di Nicola, M.; Martinotti G.; Pozzi, G.; Janiri, L.; Bria, P.; Mazza, S. Oxcarbazepine improves mood in patients with epilepsy. Epilepsy Behav. 2007, 10 (3), 397-401.

[28] Roehrs, T.; Zorick, F.; Lord, N.; Koshorek, G. L.; Roth, T. J. Clin. Psychopharmacol 1983, 3 (3), 152-6. doi:10.1097/00004714-198306000-00002

[29] Nakajima, H. A pharmacological profile of clobazam (Mystan), a new antiepileptic drug. Folia Pharmacologica Japonica 2001, 118 (2), 117-22. doi:10.1254/fpj.118.117

[30] Rooke, K. C. The use of flurazepam (dalmane) as a substitute for barbiturates and methaqualone/diphenhydramine (mandrax) in general practice. J. Int. Med. Res., 1976, 4 (5), 355-9.

[31] Verster, J. C.; Volkerts, E. R. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature. CNS Drug Rev., 2004, 10 (1), 45-76.

[32] Dahlin, M. G.; Amark, P. E.; Nergardh, A. R. Reduction of seizures with low-dose clonazepam in children with epilepsy. Pediatr. Neurol 2003, 28 (1), 48-52.

[33] Mendels, J. Evaluation of the safety and efficacy of quazepam for the treatment of insomnia in psychiatric outpatients. J. Clin. Psychiatry 1994, 55 (2), 60-5.

[34] Fann, W. E.; Pitts, W. M.; Wheless, J. C. Pharmacology, efficacy, and adverse effects of halazepam, a new benzodiazepine. Pharmacotherapy 1982, 2 (2), 72-9.

[35] Greenblatt, D. J.; Shader, R. I.; Franke, K.; Maclaughlin, D. S.; Harmatz, J. S.; Allen, M. D.; Werner, A.; Woo, E. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J. Pharm. Sci. 1991, 68 (1), 57-63. doi:10.1002/jps.2600680119

[36] Sahu, A., Das, D., Sahu, P., Mishra, S., Sakthivel, A., Gajbhiye, A. and Agrawal, R., 2019. Bioisosteric replacement of amide group with 1, 2, 3-triazoles in acetaminophen addresses reactive oxygen species-mediated hepatotoxic insult in wistar albino rats. Chemical research in toxicology, 33(2), pp.522-535.

[37] Olkkola, K. T.; Ahonen, J. Midazolam and other benzodiazepines. Handb. Exp. Pharmacol 2008, 182 (182), 335-60.

[38] Ochs, H. R.; Greenblatt, D. J.; Verburg-Ochs, B.; Locniskar, A. Comparative single‐dose kinetics of oxazolam, prazepam, and clorazepate: three precursors of desmethyldiazepam. J. Clin. Pharmacol 1984, 24 (10), 446-51.

[39] Liljequist, R.; Palva, E.; Linnoila, M. Effects on learning and memory of 2-week treatments with chlordiazepoxide lactam, N-desmethyldiazepam, oxazepam and methyloxazepam, alone or in combination with alcohol. Int Pharmacopsychiatry 1979, 14 (4), 190-8.

[40] Greenblatt, D. J.; Woo, E.; Allen, M. D.; Orsulak, P. J.; Shader, R. I. Rapid recovery from massive diazepam overdose. JAMA-J. AM. MED. ASSOC. 1978, 240 (17), 1872-4. doi:10.1001/jama.240.17.1872

[41] Rajanarendar, E.; Nagi Reddy, M.; Rama Krishna, S.; Govardhan Reddy, K.; Reddy, Y. N.; Rajam, M. V. Design, synthesis, in vitro antimicrobial and anticancer activity of novel methylenebis-isoxazolo [4, 5-b] azepines derivatives. Eur. J. Med. Chem. 2012, 50, 344-349. doi: 10.1016/j.ejmech.2012.02.013

[42] Shaik, A.B. and Prasad, Y.R., Synthesis and Antimicrobial Evaluation of Novel 1, 5-Benzothiazepine Derivatives, Journal of International Academy of Physical Sciences, 2021, 25(1), 165- 191.

[43] Duggan, L.; Fenton, M.; Dardennes, R. M.; El-Dosoky, A.; Indran, S. Olanzapine for schizophrenia. Cochrane Database of Systematic Reviews 2005, 2. doi:10.1002/14651858.

[44] Schulte, M. L.; Turlington, M. L.; Phatak, S. S.; Harp, J. M.; Staufferand, S. R.; Lindsley, C. W. Total Synthesis of Stemaphylline N-Oxide and Related C9a-Epimeric Analogues. Chem. Eur. J. 2013, 19 (36), 11847-11852. doi: 10.1002/chem.201302669

[45] Greger, H. Strudture relationships, distribution and biological activities of Stemona Alkaloids. Planta Med. 2006, 72 (2), 99-113. doi: 10.1055/s-2005-916258

[46] Pilli, R. A.; Rosso, G. B.; Oliveira, M. D. A. C. The chemistry of Stemona alkaloids: An update. Nat. Prod. Rep. 2010, 27 (12), 1908-1937. doi: 10.1039/c005018k

[47] Powell, R. G.; Weisleder, D.; Smith Jr, C. R. Antitumor Alkaloids from Cephalotaxus harringtonia: Structure and Activity. J. Pharm. Sci. 1972, 61 (8), 1227-1230. doi: 10.1002/jps.2600610812

[48] Belal, A. Design, Synthesis and Anticancer Activity Evaluation of Some Novel Pyrrolo[1,2-a]azepine Derivatives Arch. Pharm. Chem. Life Sci. 2014, 347, 515-522. doi: 10.1002/ardp.201400004

[49] Frimayanti, N., Yaeghoobi, M., Ikhtiarudin, I., Putri, D.R.W., Namavar, H. and Bitaraf, F.S., 2021. Insight on the in silico study and biological activity assay of chalcone-based 1, 5-benzothiazepines as potential inhibitor for breast cancer MCF7. CMUJ. Nat. Sci, 20(1), p.e2021019.

[50] Marchi, N., Guiso, G., Rizzi, M., Pirker, S., Novak, K., Czech, T., Baumgartner, C., Janigro, D., Caccia, S. and Vezzani, A.A pilot study on brain‐to‐plasma partition of 10, 11‐dyhydro‐10‐hydroxy‐5H‐dibenzo (b, f) azepine‐5‐carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine. 2005, Epilepsia, 46(10), pp.1613-1619.

[51] Smoller, J. W. The genetics of stress-related disorders: PTSD, depression, and anxiety disorders. Neuropsychopharmacology 2016, 41, 297−319.

[52] Rickels, K.; DeMartinis, N.; García-España, F.; Greenblatt, D. J.; Mandos, L. A.; Rynn, M. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing longterm benzodiazepine therapy. Am. J. Psychiatry 2000, 157, 1973− 1979.

[53] Rickels, K.; Chung, H. R.; Csanalosi, I. B.; Hurowitz, A. M.; London, J.; Wiseman, K.; Kaplan, M.; Amsterdam, J. D. Alprazolam, diazepam, imipramine, and placebo in outpatients with major depression. Arch. Gen. Psychiatry 1987, 44, 862−86

[54] Reamtong, O., Lapmanee, S., Tummatorn, J., Palavong, N., Thongsornkleeb, C. and Ruchirawat, S., 2021. Synthesis of Benzoazepine Derivatives via Azide Rearrangement and Evaluation of Their Antianxiety Activities. ACS Medicinal Chemistry Letters, 12(9), pp.1449-1458.

[55] Ahmad, G., Rasool, N., Rizwan, K., Imran, I., Zahoor, A.F., Zubair, M., Sadiq, A. and Rashid, U., 2019. Synthesis, in-vitro cholinesterase inhibition, in-vivo anticonvulsant activity and in-silico exploration of N-(4-methylpyridin-2-yl) thiophene-2-carboxamide analogs. Bioorganic chemistry, 92, p.103216.

[56] Kiełczewska, U., Jorda, R., Gonzalez, G., Morzycki, J.W., Ajani, H., Svrčková, K., Štěpánková, Š. and Wojtkielewicz, A., 2021. The synthesis and cholinesterase inhibitory activities of solasodine analogues with seven-membered F ring. The Journal of steroid biochemistry and molecular biology, 205, p.105776.